Physician profile
Brittany P Brown
NPI 1295328987
$14,316.66
in general payments reported to CMS, 2019-2025
19 companies · $3,504 in 2025
The $3,504 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $306 · 2023: $1,046 · 2024: $9,460 · 2025: $3,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $1,349 · Travel and Lodging: $551 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,060.00 |
| Food and Beverage | $1,349.16 |
| Travel and Lodging | $551.15 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13,393.88 | 2022-2025 | |
| Ucb, INC. | $240.71 | 2022-2023 | Briviact, Nayzilam, Fintepla |
| Lundbeck LLC | $107.80 | 2022-2023 | Vyepti |
| Lilly USA, LLC | $94.29 | 2022-2023 | Emgality, Reyvow |
| Sk Life Science, INC. | $66.37 | 2022-2023 | |
| Amgen INC. | $56.68 | 2022-2023 | Tavneos |
| Impel Pharmaceuticals INC. | $51.23 | 2023 | Trudhesa |
| Alexion Pharmaceuticals, INC. | $50.00 | 2023 | |
| Neurelis, INC. | $43.17 | 2023 | Valtoco |
| Bard Peripheral Vascular, INC. | $39.09 | 2024 | Venclose Maven Catheter |
| Biogen, INC. | $38.50 | 2022-2023 | Tysabri, Vumerity |
| Medtronic, INC. | $30.09 | 2022 | |
| Supernus Pharmaceuticals, INC. | $22.70 | 2022 | |
| Eisai INC. | $19.05 | 2023 | |
| Upsher-Smith Laboratories LLC | $17.71 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.13 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.01 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.52 | 2023 | Ajovy |
| Sumitomo Pharma America, INC. | $1.73 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.